Loading
Cardiol Therapeutics Inc. Stock: price and insider trades · Canada
Cardiol Therapeutics Inc.: what insiders have been doing
Every trade that managers of Cardiol Therapeutics Inc. disclose to SEDI is tracked on this page. The company sits in the Health Care sector. Between 21 October 2025 and 21 October 2026, 7 insiders published 13 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Insider buying of Cardiol Therapeutics Inc. has been absent for the past year. The median gap between a trade and its publication by SEDI is 3 days. Until a filing is published, the market cannot know about the trade.
Across the 2,472 companies tracked on its exchange, the median is 12 filings; at 13 filings, this issuer sits above that mark. Over the whole record (from 2018), the tally stands at 24 purchases and no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Xenon Pharmaceuticals Inc. and Vivos Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
74
Thresholds
n/a
Buy Volume
€175,610
24 ops. · all time
Sell Volume
n/a
n/a
Analyst consensus: bullish or bearish?
Analysts rate Cardiol Therapeutics Inc. Strong Buy (bullish), based on 1 analysts. Average price target: CA$7.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$1.63
Analyst consensus
1 analystsStrong buy
CA$7.00Target CA$7.00(+329%)CA$7.00
Income statement
EBITDA-CA$34.2M
Net income-CA$33.8M0.0% margin
Valuation
PER (forward)-5.0x
P/Book7.9x
Beta0.73
Balance sheet & cash
Market capCA$198.1M
Total debtCA$125.5k
Free Cash Flow-CA$23.9M
Debt / Equity0%
Profitability & ownership
ROE-190.2%
ROA-90.9%
% insiders2.3%
% institutions26.4%
Last declaration on 11 September 2026
Declarations74 total
25,000 shares@ CA$1.350.017% mcap25.2% of flowWarrantsTSXSEDI:4776854
70,000 sharesCommon Shares (Class A)TSXSEDI:4770242
70,000 sharesRights Restricted Share UnitsTSXSEDI:4770241
13,333 sharesCommon Shares (Class A)TSXSEDI:4767475
13,333 sharesRights Restricted Share UnitsTSXSEDI:4767474
13,333 sharesCommon Shares (Class A)TSXSEDI:4767465
13,333 sharesRights Restricted Share UnitsTSXSEDI:4767462
45,238 sharesRights Restricted Share UnitsTSXSEDI:4745488
30,000 sharesRights Restricted Share UnitsTSXSEDI:4745476
30,000 sharesRights Restricted Share UnitsTSXSEDI:4745464
133,334 sharesCommon Shares (Class A)TSXSEDI:4603420
50,000 shares@ CA$1.0044.5% of flowCommon Shares (Class A)TSXSEDI:4595020
100,000 shares@ CA$1.0063.2% of flowCommon Shares (Class A)TSXSEDI:4595014
13,334 sharesCommon Shares (Class A)TSXSEDI:4576167
70,000 sharesCommon Shares (Class A)TSXSEDI:4576160
13,334 sharesCommon Shares (Class A)TSXSEDI:4576181
20,000 sharesCommon Shares (Class A)TSXSEDI:4496730
44,955 shares@ CA$0.523Common Shares (Class A)TSXSEDI:4313638
Canonical exit: 27 Mar 2023 (T+90)
18,245 shares@ CA$0.5175Common Shares (Class A)TSXSEDI:4313639
Canonical exit: 28 Mar 2023 (T+90)
60,000 sharesCommon Shares (Class A)TSXSEDI:4299335
20,000 shares@ CA$3.2586.0% of flowCommon Shares (Class A)TSXSEDI:3817971
4,336 shares@ CA$5.7024.6% of flowCommon Shares (Class A)TSXSEDI:3811418
50,000 sharesCommon Shares (Class A)TSXSEDI:3811260
3,496 shares@ CA$3.229.1% of flowCommon Shares (Class A)TSXSEDI:3803638
200,000 sharesCommon Shares (Class A)TSXSEDI:3803553
25 of 74 declarations
About Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc. is a biopharmaceutical company focused on developing therapies for cardiovascular diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
